אולנזפין טבע ® 15 מ"ג

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

OLANZAPINE 15 MG

Pieejams no:

SALOMON,LEVIN & ELSTEIN LTD

ATĶ kods:

N05AH03

Zāļu forma:

FILM COATED TABLETS

Ievadīšanas:

PER OS

Ražojis:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Ārstniecības grupa:

OLANZAPINE

Ārstēšanas norādes:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Autorizācija datums:

2011-04-01